LBF20115PG01: Difference between revisions
No edit summary |
No edit summary |
||
| Line 8: | Line 8: | ||
|SysName=9alpha-hydroxy-11,15-dioxo-prost-5Z-en-1-oic acid | |SysName=9alpha-hydroxy-11,15-dioxo-prost-5Z-en-1-oic acid | ||
|Common Name=&&13,14-dihydro-15keto Prostaglandin D_2&&9alpha-hydroxy-11,15-dioxo-prost-5Z-en-1-oic acid&& | |Common Name=&&13,14-dihydro-15keto Prostaglandin D_2&&9alpha-hydroxy-11,15-dioxo-prost-5Z-en-1-oic acid&& | ||
|Source=13,14-dihydro-15keto PGD2 is a metabolite of PGD2 which is formed through the PG 15-dehydrogenase pathway.[[Reference:Hirata_Y:Hayashi_H:Ito_S:Kikawa_Y:Ishibashi_M:Sudo_M:Miyazaki_H:Fukushima_M:Narumiya_S:Hayaishi_O:,J. Biol. Chem.,1988,263,16619|{{RelationTable/GetFirstAuthor|Reference:Hirata_Y:Hayashi_H:Ito_S:Kikawa_Y:Ishibashi_M:Sudo_M:Miyazaki_H:Fukushima_M:Narumiya_S:Hayaishi_O:,J. Biol. Chem.,1988,263,16619}}]] | |Source=13,14-dihydro-15keto PGD2 is a metabolite of PGD2 which is formed through the PG 15-dehydrogenase pathway.[[Reference:Hirata_Y:Hayashi_H:Ito_S:Kikawa_Y:Ishibashi_M:Sudo_M:Miyazaki_H:Fukushima_M:Narumiya_S:Hayaishi_O:,J. Biol. Chem.,1988,263,16619|{{RelationTable/GetFirstAuthor|Reference:Hirata_Y:Hayashi_H:Ito_S:Kikawa_Y:Ishibashi_M:Sudo_M:Miyazaki_H:Fukushima_M:Narumiya_S:Hayaishi_O:,J. Biol. Chem.,1988,263,16619}}]] | ||
|Chemical Synthesis= | |Chemical Synthesis= | ||
|Metabolism= | |Metabolism= | ||
Revision as of 20:55, 25 November 2009
| LipidBank Top (トップ) |
Fatty acid (脂肪酸) |
Glycerolipid (グリセロ脂質) |
Sphingolipid (スフィンゴ脂質) |
Journals (雑誌一覧) |
How to edit (ページの書き方) |
| IDs and Links | |
|---|---|
| LipidBank | XPR1704 |
| LipidMaps | LMFA03010022 |
| CAS | |
| KEGG | {{{KEGG}}} |
| KNApSAcK | {{{KNApSAcK}}} |
| mol | LBF20115PG01 |
| 13,14-dihydro-15keto Prostaglandin D2 | |
|---|---|
| |
| Structural Information | |
| 9α-hydroxy-11,15-dioxo-prost-5Z-en-1-oic acid | |
| |
| Formula | C20H32O5 |
| Exact Mass | 352.224974134 |
| Average Mass | 352.46508 |
| SMILES | C(CCC(=O)CC[C@H]([C@H]1CC=CCCCC(O)=O)C(C[C@@H]1O)=O)CC |
| Physicochemical Information | |
| 13,14-dihydro-15keto PGD2 is a metabolite of PGD2 which is formed through the PG 15-dehydrogenase pathway. Hirata_Y et al. | |
| Spectral Information | |
| Mass Spectra | |
| UV Spectra | |
| IR Spectra | |
| NMR Spectra | |
| Other Spectra | |
| Chromatograms | |
| Reported Metabolites, References | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
|
